TELNIVOC-M FORTE

Telnivoc-M FORTE combines Teneligliptin, a DPP-4 inhibitor, with high-strength Metformin Hydrochloride (Extended Release) to provide enhanced glycaemic control for patients with type 2 diabetes mellitus.

• Teneligliptin helps regulate blood sugar by increasing insulin secretion and decreasing glucagon release.

• Metformin ER improves insulin sensitivity and reduces glucose production in the liver.
  This powerful combination is especially suited for patients requiring stronger control over elevated blood glucose levels.

Benefits:

• Effective in reducing HbA1c levels and maintaining long-term sugar control.

• High-dose Metformin ER ensures better insulin utilisation and extended action.

• Controls both fasting and post-meal glucose.

• Reduces risk of diabetes-related complications when used with lifestyle changes.

• Convenient once or twice daily dosing for better compliance.

Dosage:

• Adults: Usually 1 tablet once daily, with or after meals, or as directed by the physician.

Why Cardiever?

• GMP & ISO-certified manufacturing ensuring high safety standards.

• Formulated with accurate dosing for maximum therapeutic effect.

• Trusted by healthcare professionals for quality and reliability.

• Backed by strict quality control and clinical validation.